Surmodics | SRDX - Assets


Surmodics reported $178.56M in Assets for its fiscal quarter ending in September of 2024.





Assets Change Date
Abbott USD 84.18B 182M Sep/2025
Align Technology USD 6.23B 141K Dec/2025
Anika Therapeutics USD 189.44M 1.76M Sep/2025
Arrowhead Research USD 1.6B 218.89M Dec/2025
Baxter International USD 21.07B 21M Sep/2025
Boston Scientific USD 42.71B 1.15B Sep/2025
EDAP TMS EUR 61.46M 6.88M Sep/2025
Edwards Lifesciences USD 13.27B 216.5M Sep/2025
Haemonetics USD 2.49B 48.73M Dec/2025
Heron Therapeutics USD 248.95M 16.86M Sep/2025
J&J USD 199.21B 6.39B Dec/2025
Merit Medical Systems USD 2.63B 44.95M Sep/2025
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Nektar Therapeutics USD 301.35M 93.81M Sep/2025
Option Care Health USD 3.48B 97.02M Sep/2025
Stryker USD 47.84B 787M Dec/2025
Surmodics USD 178.56M 1.15M Sep/2024
Trinity Biotech USD 103.71M 4.08M Sep/2025